Usefulness of tocilizumab for treating rheumatoid arthritis with myelodysplastic syndrome: A case report and literature review

RATIONALE: Dysregulated immune function in rheumatoid arthritis (RA) might lead to the development of myelodysplastic syndrome (MDS). Serum interleukin-6 (IL-6) concentrations are increased in both RA and MDS patients. PATIENT CONCERNS: A 58-year-old woman presented with severe RA. During a recent 8...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Chuanyin, Luo, Yingwan, Tong, Hongyan, Xu, Guanhua, Lin, Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023877/
https://www.ncbi.nlm.nih.gov/pubmed/29924032
http://dx.doi.org/10.1097/MD.0000000000011179

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023877/
https://www.ncbi.nlm.nih.gov/pubmed/29924032
http://dx.doi.org/10.1097/MD.0000000000011179

Ejemplares similares